Literature DB >> 23427068

Risk factors for the development of vertebral fractures after percutaneous vertebroplasty.

Angeles Martinez-Ferrer1, Jordi Blasco, Josep Li Carrasco, Juan M Macho, Luis San Román, Antonio López, Ana Monegal, Nuria Guañabens, Pilar Peris.   

Abstract

We have recently observed an increased risk for vertebral fractures (VF) in a randomized controlled trial comparing the analgesic effect of vertebroplasty (VP) versus conservative treatment in symptomatic VF. The aim of the present study was to evaluate the risk factors related to the development of VF after VP in these patients. We evaluated risk factors including age, gender, bone mineral density, the number, type, and severity of vertebral deformities at baseline, the number of vertebral bodies treated, the presence and location of disk cement leakage, bone remodeling (determining bone turnover markers) and 25 hydroxyvitamin D [25(OH)D] levels at baseline in all patients. Twenty-nine radiologically new VF were observed in 17 of 57 patients undergoing VP, 72% adjacent to the VP. Patients developing VF after VP showed an increased prevalence of 25(OH)D deficiency (<20 ng/mL) and higher P1NP values. The principal factor related to the development of VF after VP in multivariate analysis was 25(OH)D levels < 20 ng/mL (RR, 15.47; 95% CI, 2.99-79.86, p < 0.0001), whereas age >80 years (RR, 3.20; 95% CI, 1.70-6.03, p = 0.0007) and glucocorticoid therapy (RR, 3.64; 95% CI, 1.61-8.26, p = 0.0055) constituted the principal factors in the overall study population. Increased risk of VF after VP was also associated with cement leakage into the inferior disk (RR, 6.14; 95% CI, 1.65-22.78, p = 0.044) and more than one vertebral body treated during VP (RR, 4.19; 95% CI, 1.03-34.3, p = 0.044). In conclusion, nearly 30% of patients with osteoporotic VF treated with VP had a new VF after the procedure. Age, especially >80 years, the presence of inferior disk cement leakage after the procedure, the number of cemented vertebrae, and low 25(OH)D serum levels were related to the development of new VF in these patients, with the latter indicating the need to correct vitamin D deficiency prior to performing VP.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Keywords:  FRAGILITY FRACTURE; OSTEOPOROTIC FRACTURE; VERTEBRAL FRACTURE; VERTEBROPLASTY

Mesh:

Year:  2013        PMID: 23427068     DOI: 10.1002/jbmr.1899

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Vertebral fractures cascade: potential causes and risk factors.

Authors:  H Che; V Breuil; B Cortet; J Paccou; T Thomas; L Chapuis; F Debiais; N Mehsen-Cetre; R M Javier; S Loiseau Peres; C Roux; K Briot
Journal:  Osteoporos Int       Date:  2018-12-05       Impact factor: 4.507

2.  Letter to the Editor concerning "Risk factors of new symptomatic vertebral compression fractures in osteoporotic patients undergone percutaneous vertebroplasty" by HL. Ren et al. (Eur Spine J; 2015;24(4):750-758).

Authors:  Zhihui Dai; Ding-Jun Hao; Guo-Hua Lv; Jing Li; Ming-Xiang Zou; Ming Yang
Journal:  Eur Spine J       Date:  2017-03-06       Impact factor: 3.134

3.  Therapeutic effects of PKP on chronic painful osteoporotic vertebral compression fractures with or without intravertebral cleft.

Authors:  Debo Zou; Kaining Zhang; Yanjun Ren
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 4.  Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures.

Authors:  O Lamy; B Uebelhart; B Aubry-Rozier
Journal:  Osteoporos Int       Date:  2013-11-22       Impact factor: 4.507

5.  Osteoporosis associated vertebral fractures-Health economic implications.

Authors:  Julian Joestl; Nikolaus Lang; Adam Bukaty; Thomas M Tiefenboeck; Patrick Platzer
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

Review 6.  Network meta-analysis of percutaneous vertebroplasty, percutaneous kyphoplasty, nerve block, and conservative treatment for nonsurgery options of acute/subacute and chronic osteoporotic vertebral compression fractures (OVCFs) in short-term and long-term effects.

Authors:  Xiao-Hua Zuo; Xue-Piao Zhu; Hong-Guang Bao; Chen-Jie Xu; Hao Chen; Xian-Zhong Gao; Qian-Xi Zhang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  Effects of Polymethylmethacrylate Cement Viscosity and Bone Porosity on Cement Leakage and New Vertebral Fractures After Percutaneous Vertebroplasty: A Prospective Study.

Authors:  Mohamed Alhashash; Mootaz Shousha; Ahmed Samir Barakat; Heinrich Boehm
Journal:  Global Spine J       Date:  2019-02-28

Review 8.  Vertebroplasty for osteoporotic vertebral fracture.

Authors:  Christian Roux; Bernard Cortet; Valérie Bousson; Thierry Thomas
Journal:  RMD Open       Date:  2021-06

Review 9.  The Incidence of New Vertebral Fractures Following Vertebral Augmentation: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Weixing Xie; Daxiang Jin; Chao Wan; Jinyong Ding; Shuncong Zhang; Xiaobing Jiang; Jixi Xu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  The risk factors of vertebral refracture after kyphoplasty in patients with osteoporotic vertebral compression fractures: a study protocol for a prospective cohort study.

Authors:  Lei Feng; Chun Feng; Jie Chen; Yu Wu; Jin-Ming Shen
Journal:  BMC Musculoskelet Disord       Date:  2018-07-02       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.